Current therapeutic strategies for anxious depressives

References

• Stahl S. Mixed anxiety and depression: clinical implications. J: Clin. Psychiatry 54(Suppl.) 33–38 (1993).
   Google Scholar
• Postemak MA, Zimmerman M. The prevalence of atypical features across mood, anxiety and personality disorders. Comp: Psychiatry 43(4), 253–262 (2000).
   Google Scholar
• Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JE Major depressive subtypes and treatment response. Biol. Psych/at. 42 (7), 568–76 (1997).
   PubMed Web of Science ®Google Scholar
• Grunhaus L, Rabin D, Greden JE Simultaneous panic and depressive disorder: response to antidepressant treatments. J: Clin. Psychiatry 47(1), 4–7 (1986).
   Google Scholar
• Grunhaus L. Clinical and psychobiological characteristics of simultaneous panic disorder and major depression. Am. J: Psychiatry 145(10), 1214–1221 (1998).
   Google Scholar
• Roy-Byrne P. Anxiety in primary care depression: how does it lead to poor outcomes and what can we do about it? Gen. Hosp. PFhiatry21 (3), 151–153 (1999).
   Google Scholar
• Goldberg D. The management of anxious depression in primary care. J: Clin. Psychiatry60 (Suppl. 7) 39–42 (1999).
   Google Scholar
• Zimmerman M, Chelminski I, McDermut W Major depressive disorder and Axis I diagnostic comorbidity. j Clin. Psychiatry 63(3), 187–193 (2002).
   Google Scholar
• •Well-designed, well-controlled, prospective study in 479 patients. The authors noted that the amount of comorbidity detected was affected by how detailed the assessment was, with more comorbidity being detected with more thorough assessments.
   Google Scholar
• de Graaf R, Biji RV, Smit F, Vollebergh WA, Spijker J. Risk factors for 12-month comorbidity of mood, anxiety and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am. J: PFhiatry159(4), 620–629 (2002).
   Google Scholar
• •The sample size in this prospective study, over 7000 patients, is extremely impressive. The results that most cases of major depression occur with another comorbid diagnosis are compelling.
   Google Scholar
• Melartin TK, Rytsala HJ, Leskela US, Lestela-Mielonen PS, Sokero TP, Isometsa ET. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J: Clin. Psychiatry 63(2), 126–134 (2002).
   Google Scholar
• ••This study prospectively examined bothAxis I and II diagnoses, and shows clearly that when taken together nearly 80% of patients with a major depression have another diagnosis.
   Google Scholar
• Rapaport MET. Prevalence, recognition and treatment of comorbid depression and anxiety. I Clin.fiychiatry 62\(Suppl. 24), 6–
   Google Scholar
• •Reviews recent publications on comorbidity and comes to the very important recognition that comorbidity is the norm and not the exception of major depressive disorder.
   Google Scholar
• Wittchen HU, Lieb R, Wunderlich U, Schuster P Comorbidity in primary care: presentation and consequences. J. Clin. fiychiatry60 (Suppl. 7), 29–36 (1999).
   Google Scholar
• Kendler KS. Major depression and generalised anxiety disorder. Same genes, (partly) different environments — revisited. Br. Psychiatry30(Suppl.) 68–75 (1996).
   Google Scholar
• Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves U. Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch. Gen. Psychiatry 49(9), 716–722 (1992).
   Google Scholar
• Roy MA, Neale MC, Pedersen NL, Mathe AA, Kendler KS. A twin study of generalized anxiety disorder and major depression. Psychol. Merl 25(5), 1037–1049 (1995).
   Google Scholar
• Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves U. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression and alcoholism. Arch. Gen. Psychiatry52(5), 374–383 (1995).
   Google Scholar
• Woodman CL. The genetics of panic disorder and generalized anxiety disorder. Ann. Glitz Psychiatry5(4), 231–239 (1993).
   Google Scholar
• Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves U. Major depression and phobias: the genetic and environmental sources of morbidity. Psychol. Merl 23(2), 361–371 (1993).
   Google Scholar
• Pauls DL, Leckman JF, Cohen DJ. Evidence against a genetic relationship between Tourette's syndrome and anxiety, depression, panic and phobic disorders. BE Psychiatry164(2), 215–221 (1994).
   Google Scholar
• Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety 12 (Suppl. 1), 2–19 (2000).
   Google Scholar
• Meller WH, Kathol RG, Samuelson SD etal CRTI challenge test in anxiousdepression. Biol. Psychiatry 37(6), 376–382 (1995).
   Google Scholar
• Ravindran AV, Judge R, Hunter BN, Bray J, Morton NH. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group. J. Clin. Ptychiatry58(3), 112–118 (1997).
   Google Scholar
• Rudolph RL, Entsuah R, Chitra R. A meta- analysis of the effects of venlafaxine on anxiety associated with depression. J. Clin. Ptychopharmacol 18(2), 136–144 (1998).
   Google Scholar
• Marchesi C, Ceccherininelli A, Rossi A, Maggini C. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline. Phannacopsychiatry 31 (6), 216–221 (1998).
   Google Scholar
• Versiani M, Ontiveros A, Mazzotti G etal. Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison. int. Glitz Ptychopharmacol 14(6), 321–327 (1999).
   Google Scholar
• Fawcett J, Barkin RL. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. J. Clin. Psychiatry 59(3), 123–127 (1998).
   Google Scholar
• Silverstone PH, Ravindran A. Efficacy and tolerability of once-daily venlafaxine XR vs. fluoxetine in depressed out-patients with concomitant anxiety. J. Clin. Psychiatry 60, 22–28 (1999).
   Google Scholar
• Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J. Affect. Disord. 59(2), 119–126 (2000).
   Google Scholar
• Trivedi MET, Rush AJ, Carmody TJ etal Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?j Clin. Ptychiatry 62 (10), 776–781 (2001).
   Google Scholar
• Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Depress. Anxiety16(1), 4–13 (2002).
   Google Scholar